Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: campe who wrote (294)	12/11/1998 3:16:00 PM
From: Bear Down	Respond to of 1084

or an orchestrated attempt to keep it marginable and avoind the margin calls for the weekend

To: campe who wrote (294)	12/11/1998 3:21:00 PM
From: JSB	Read Replies (2) \| Respond to of 1084

If there is a Times article over the weekend, the shorters will not be able to keep us down. Bummer, huh :) Regards, JSB

To: campe who wrote (294)	12/11/1998 9:19:00 PM
From: John Miz	Read Replies (1) \| Respond to of 1084

My apologies if this has been posted already, but here is the link to last night's story on NBC Nightly News.... msnbc.com You will see Dr. Joanne Kurtzberg, of Duke University Medical Center, prominently mentioned in the article. How is she connected to ASTM? Dr. Kurtzberg is the lead investigator for one of the clinical trials that are underway to evaluate the AastromReplicell System that has been developed by ASTM. Key observation so far: Better 100-day survival reported. Jophn